828 related articles for article (PubMed ID: 15196571)
1. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
[TBL] [Abstract][Full Text] [Related]
2. [Antagonistic interaction between Clostridium butyricum and enterohemorrhagic Escherichia coli O157:H7].
Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Sakazaki R; Kamiya S
Kansenshogaku Zasshi; 1999 Jan; 73(1):7-14. PubMed ID: 10077896
[TBL] [Abstract][Full Text] [Related]
3. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
[TBL] [Abstract][Full Text] [Related]
4. Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains.
Yoshimura K; Matsui T; Itoh K
Antonie Van Leeuwenhoek; 2010 Feb; 97(2):107-17. PubMed ID: 19911297
[TBL] [Abstract][Full Text] [Related]
5. Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice.
Gagnon M; Kheadr EE; Dabour N; Richard D; Fliss I
Int J Food Microbiol; 2006 Aug; 111(1):26-33. PubMed ID: 16822570
[TBL] [Abstract][Full Text] [Related]
6. Competition for proline between indigenous Escherichia coli and E. coli O157:H7 in gnotobiotic mice associated with infant intestinal microbiota and its contribution to the colonization resistance against E. coli O157:H7.
Momose Y; Hirayama K; Itoh K
Antonie Van Leeuwenhoek; 2008 Aug; 94(2):165-71. PubMed ID: 18247153
[TBL] [Abstract][Full Text] [Related]
7. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7.
Carey CM; Kostrzynska M; Ojha S; Thompson S
J Microbiol Methods; 2008 May; 73(2):125-32. PubMed ID: 18328583
[TBL] [Abstract][Full Text] [Related]
8. B-cell epitope KT-12 of enterohemorrhagic Escherichia coli O157:H7: a novel peptide vaccine candidate.
Wan CS; Zhou Y; Yu Y; Peng LJ; Zhao W; Zheng XL
Microbiol Immunol; 2011 Apr; 55(4):247-53. PubMed ID: 21272063
[TBL] [Abstract][Full Text] [Related]
9. [New knowledge of the molecular biology of enterohemorrhagic Escherichia coli (EHEC) O157].
Karch H; Köhler B
Gesundheitswesen; 1999 Oct; 61 Spec No 1():S46-51. PubMed ID: 10593045
[TBL] [Abstract][Full Text] [Related]
10. Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins.
Liu J; Sun Y; Feng S; Zhu L; Guo X; Qi C
Vaccine; 2009 Oct; 27(43):5929-35. PubMed ID: 19682616
[TBL] [Abstract][Full Text] [Related]
11. Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection.
Cai K; Gao X; Li T; Wang Q; Hou X; Tu W; Xiao L; Tian M; Liu Y; Wang H
Vaccine; 2011 Jan; 29(5):946-52. PubMed ID: 21134452
[TBL] [Abstract][Full Text] [Related]
12. The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli.
Shimizu T; Kawakami S; Sato T; Sasaki T; Higashide M; Hamabata T; Ohta T; Noda M
Infect Immun; 2007 May; 75(5):2189-200. PubMed ID: 17325057
[TBL] [Abstract][Full Text] [Related]
13. Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer's patches.
Thévenot J; Cordonnier C; Rougeron A; Le Goff O; Nguyen HT; Denis S; Alric M; Livrelli V; Blanquet-Diot S
Appl Microbiol Biotechnol; 2015 Nov; 99(21):9097-110. PubMed ID: 26084888
[TBL] [Abstract][Full Text] [Related]
14. Detection of enterohemorrhagic Escherichia coli O157:H7 by using a multiplex real-time PCR assay for genes encoding intimin and Shiga toxins.
Sharma VK; Dean-Nystrom EA
Vet Microbiol; 2003 May; 93(3):247-60. PubMed ID: 12695048
[TBL] [Abstract][Full Text] [Related]
15. Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle.
Baker DR; Moxley RA; Steele MB; Lejeune JT; Christopher-Hennings J; Chen DG; Hardwidge PR; Francis DH
Appl Environ Microbiol; 2007 Nov; 73(22):7338-46. PubMed ID: 17890332
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Clostridium species lower host susceptibility to enterohemorrhagic Escherichia coli O157:H7 infection.
Koyanagi Y; Suzuki R; Ihara K; Miyagi H; Isogai H; Yoneyama H; Isogai E
Pathog Dis; 2019 Jun; 77(4):. PubMed ID: 31344225
[TBL] [Abstract][Full Text] [Related]
17. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli in white veal calves.
Cristancho L; Johnson RP; McEwen SA; Gyles CL
Vet Microbiol; 2008 Jan; 126(1-3):200-9. PubMed ID: 17656044
[TBL] [Abstract][Full Text] [Related]
18. Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB/c mice.
Rahal EA; Kazzi N; Kanbar A; Abdelnoor AM; Matar GM
Int J Antimicrob Agents; 2011 Feb; 37(2):135-9. PubMed ID: 21129928
[TBL] [Abstract][Full Text] [Related]
19. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH
Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158
[TBL] [Abstract][Full Text] [Related]
20. Detection of Shiga toxin genes stx1, stx2, and the +93 uidA mutation of E. coli O157:H7/H-using SYBR Green I in a real-time multiplex PCR.
Yoshitomi KJ; Jinneman KC; Weagant SD
Mol Cell Probes; 2006 Feb; 20(1):31-41. PubMed ID: 16271448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
